FACS Forum encouraged by European Medicines Agency’s latest measures on Sodium Valproate in pregnancy
FACS Forum encouraged by European Medicines Agency's latest measures
FACS Forum encouraged by European Medicines Agency's latest measures
Stopping epilepsy before it begins?
New genetic test can predict adverse reactions to epilepsy drug
Patients with Lennox-Gastaut syndrome improve after cannabidiol treatment
Largest ever neuroimaging study of people with epilepsy
Dáil to vote on medicinal cannabis bill this week
Researchers collect largest recorded collection of families with epilepsy
Liane died 6 months ago today
EMA takes yet another step in public engagement with its first public hearing
Yesterday (September 26th), Karen Keely of the FACS Forum Ireland addressed the EMA's public hearing on valproate in London. The hearing was investigating whether 2014 European-wide measures to restrict the use of valproate in girls and women of childbearing potential have been effective and whether additional measures to reduce risks associated with the drug are needed.